Medtronic PLC vs Valero Energy Corporation — how do they compare? Medtronic PLC trades at $87.92 (market cap $112.24B), while Valero Energy Corporation trades at $439.78 (market cap $127.78B). The key difference: Medtronic PLC and Valero Energy Corporation are close in size by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Valero Energy Corporation for 56 Days on average.
| MDT | VLO | |
|---|---|---|
Market Cap | $112.24B | $127.78B |
Volume | 105,663,236 | 2,570,225 |
Sector | Health | Energy |
52-Week High | $105.35 | $443.80 |
52-Week Low | $73.75 | $156.39 |
Typical Hold Time | 63 Days | 56 Days |
Enterprise Value | $131.58B | $131.26B |
Dividend Yield | 3.28% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $85.51, down 1.81% on the day, showing bearish technical signals despite strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending, while maintaining robust profitability margins of 65% gross and 14% net. Recent news highlights the company's 49-year dividend growth streak and new product approvals, though technical indicators show selling pressure with the stock trading near support at $85.
MDT presents a compelling value opportunity with a 3.2% dividend yield and 14% upside to the $97.80 consensus target, though near-term technical weakness and increasing debt levels warrant caution. The company's consistent earnings beats and medical device market leadership support long-term growth, while regulatory approvals for new systems provide catalysts.
Valero Energy (VLO) trades at $424.10, up 1.16% with strong technical momentum and bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $176.4B in 2022 to $122.7B in 2025. Analyst consensus remains positive with 57% buy ratings, though the current price exceeds the $408.10 consensus target. Recent news highlights refining sector strength and institutional buying interest.
VLO presents a mixed outlook with strong operational performance offset by revenue pressures. The stock's premium valuation (P/E 17.69) and overbought RSI suggest near-term caution, but projected 2026 earnings growth ($7.2B net income) and dividend yield provide support. Key risks include refining margin volatility and potential policy impacts from diesel export restrictions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →